Cargando…

Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster Vaccination

The emergence of SARS-CoV-2 Omicron subvariants prompted countries to call for accelerated booster vaccinations to limit disease and transmission. Here, we characterized correlates of protection over time after the second booster or after Omicron BA.1 infection comparing variants of concern (VOCs)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Grikscheit, Katharina, Rabenau, Holger F., Ghodratian, Zahra, Widera, Marek, Wilhelm, Alexander, Toptan Grabmair, Tuna, Hoehl, Sebastian, Layer, Emily, Helfritz, Fabian, Ciesek, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323888/ https://www.ncbi.nlm.nih.gov/pubmed/35891326 http://dx.doi.org/10.3390/vaccines10071163

Ejemplares similares

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
por: Wilhelm, Alexander, et al.
Publicado: (2022)

Low But Recoverable Markers of Humoral Immune Response to BNT162b2 in Elderly LTCF Residents Five to Seven Months After Two-Dose Vaccination
por: Delbrück, Marla, et al.
Publicado: (2022)

The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro
por: Kohmer, Niko, et al.
Publicado: (2021)

Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
por: Widera, Marek, et al.
Publicado: (2021)

Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study
por: Kohmer, Niko, et al.
Publicado: (2023)

Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs
por: Toptan, Tuna, et al.
Publicado: (2020)

Comparison of the Ct-values for genomic and subgenomic SARS-CoV-2 RNA reveals limited predictive value for the presence of replication competent virus
por: Roesmann, Fabian, et al.
Publicado: (2023)

Thirty years of CMV seroprevalence—a longitudinal analysis in a German university hospital
por: Hoehl, Sebastian, et al.
Publicado: (2020)

Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q
por: Wilhelm, Alexander, et al.
Publicado: (2021)

Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics
por: Veleanu, Andrei, et al.
Publicado: (2022)

Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?
por: Toptan, Tuna, et al.
Publicado: (2021)

Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs)
por: Kohmer, Niko, et al.
Publicado: (2021)

SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach
por: Layer, Emily, et al.
Publicado: (2022)

Increasing but insufficient neutralizing activity against Omicron-BA.1 after a second booster dose of mRNA-1273 vaccine in chronic haemodialysis patients
por: Ovcar, Eugen, et al.
Publicado: (2022)

Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and Cellular Factors Limiting SARS-CoV-2 Replication
por: Widera, Marek, et al.
Publicado: (2021)

Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
por: Shalamova, Lyudmila, et al.
Publicado: (2022)

Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators
por: Van, Nguyen Dinh, et al.
Publicado: (2016)

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
por: Bojkova, Denisa, et al.
Publicado: (2022)

Die Virologie von SARS-CoV-2
por: Hoehl, S., et al.
Publicado: (2020)

Die Virologie von SARS-CoV-2
por: Hoehl, S., et al.
Publicado: (2020)

Die Virologie von SARS-CoV-2
por: Hoehl, S., et al.
Publicado: (2020)

Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies
por: Kohmer, Niko, et al.
Publicado: (2021)

Recalling ancestral SARS-CoV-2 variants: is it an original sin with benefits?
por: Hoehl, Sebastian, et al.
Publicado: (2023)

Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study
por: Koehm, Michaela, et al.
Publicado: (2023)

Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
por: Muik, Alexander, et al.
Publicado: (2022)

Is Olfactory Testing a Useful Diagnostic Tool to Identify SARS-CoV-2 Infections Early? A Cross-Sectional and Longitudinal Analysis
por: Graf, Christiana, et al.
Publicado: (2023)

Clinical performance of different SARS‐CoV‐2 IgG antibody tests
por: Kohmer, Niko, et al.
Publicado: (2020)

Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays
por: Kohmer, Niko, et al.
Publicado: (2020)

Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
por: Patyna, Sammy, et al.
Publicado: (2022)

Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7
por: Widera, Marek, et al.
Publicado: (2021)

Machine learning on large scale perturbation screens for SARS-CoV-2 host factors identifies β-catenin/CBP inhibitor PRI-724 as a potent antiviral
por: Kelch, Maximilian A., et al.
Publicado: (2023)

Treatment of SARS with human interferons
por: Cinatl, J, et al.
Publicado: (2003)

A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated
por: Hoehl, Sebastian, et al.
Publicado: (2021)

Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma
por: Enssle, Julius C., et al.
Publicado: (2022)

Interferon Gamma in Leishmaniasis
por: Kima, Peter E., et al.
Publicado: (2013)

Suitability of Different Diagnostic Platforms for Virological Testing of Blood Samples from Cornea Donors
por: Kohmer, Niko, et al.
Publicado: (2022)

Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma
por: Enssle, Julius Christoph, et al.
Publicado: (2022)

Treatment of SARS with human interferons
por: Cinatl, J, et al.
Publicado: (2003)

Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma
por: Enßle, Julius C., et al.
Publicado: (2022)

Reply to Fabbris et al. A Viable Alternative. Comment on “Kohmer et al. Self-Collected Samples to Detect SARS-CoV-2: Direct Comparison of Saliva, Tongue Swab, Nasal Swab, Chewed Cotton Pads and Gargle Lavage. J. Clin. Med. 2021, 10, 5751”
por: Hoehl, Sebastian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_japj1ie7sh9pk25o2c75pb1eop